Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 7, 2018

Total Value ($000): $211,385 (100.0% shares, 0.0% debt)

Holdings (14)

REPL Replimune 38.9%

Value ($000) $82,166 Shares 5,103,455 Est. Cost $17.53 Unrealized 0.0%

— Paratek Pharmaceuticals 11.9%

Value ($000) $25,224 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Translate Bio 11.5%

Value ($000) $24,376 Shares 2,437,601 Est. Cost $12.65 Unrealized —

— ObsEva 8.5%

Value ($000) $18,019 Shares 999,364 Est. Cost $9.76 Unrealized —

— Kezar Life Sciences 7.0%

Value ($000) $14,843 Shares 693,272 Est. Cost $17.30 Unrealized —

SNNAQ Sienna Biopharmaceuticals 5.3%

Value ($000) $11,243 Shares 758,610 Est. Cost $21.95 Unrealized -27.6%

— FibroGen 3.8%

Value ($000) $7,937 Shares 130,646 Est. Cost $27.34 Unrealized —

— Cidara Therapeutics 3.1%

Value ($000) $6,639 Shares 1,508,794 Est. Cost $6.73 Unrealized —

— CymaBay Therapeutics 2.9%

Value ($000) $6,110 Shares 551,477 Est. Cost $4.71 Unrealized —

— Pieris Pharmaceuticals 2.1%

Value ($000) $4,358 Shares 778,230 Est. Cost $1.83 Unrealized —

— Jounce Therapeutics 1.6%

Value ($000) $3,445 Shares 529,965 Est. Cost $21.99 Unrealized —

— Dicerna Pharmaceuticals 1.6%

Value ($000) $3,410 Shares 223,457 Est. Cost $16.47 Unrealized —

— ESSA Pharma 1.5%

Value ($000) $3,256 Shares 1,084,848 Est. Cost $3.00 Unrealized —

— Egalet 0.2%

Value ($000) $359 Shares 2,889,926 Est. Cost $5.98 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune	5,103,455	$82,166	38.9%	$17.53	0.0%	Common Stock	76029N106
—	Paratek Pharmaceuticals	2,600,410	$25,224	11.9%	$34.18	—	Common Stock	699374302
—	Translate Bio	2,437,601	$24,376	11.5%	$12.65	—	Common Stock	89374L104
—	ObsEva	999,364	$18,019	8.5%	$9.76	—	Common Stock	H5861P103
—	Kezar Life Sciences	693,272	$14,843	7.0%	$17.30	—	Common Stock	49372L100
SNNAQ	Sienna Biopharmaceuticals	758,610	$11,243	5.3%	$21.95	-27.6%	Common Stock	82622H108
—	FibroGen	130,646	$7,937	3.8%	$27.34	—	Common Stock	31572Q808
—	Cidara Therapeutics	1,508,794	$6,639	3.1%	$6.73	—	Common Stock	171757107
—	CymaBay Therapeutics	551,477	$6,110	2.9%	$4.71	—	Common Stock	23257D103
—	Pieris Pharmaceuticals	778,230	$4,358	2.1%	$1.83	—	Common Stock	720795103
—	Jounce Therapeutics	529,965	$3,445	1.6%	$21.99	—	Common Stock	481116101
—	Dicerna Pharmaceuticals	223,457	$3,410	1.6%	$16.47	—	Common Stock	253031108
—	ESSA Pharma	1,084,848	$3,256	1.5%	$3.00	—	Common Stock	29668H708
—	Egalet	2,889,926	$359	0.2%	$5.98	—	Common Stock	28226B104